Department of Biotechnology (DBT)
Government
Closing soon

DBT-BIRAC Joint Call for Proposals on Bio AI for Fostering High Performance Biomanufacturing under BioE3 Policy — Eligibility Criteria

Eligibility

DBT-BIRAC Joint Call for Proposals on Bio AI for Fostering High Performance Biomanufacturing under BioE3 Policy is open to idea · product-stage startups registered in India. The full eligibility criteria — qualifying sectors, states and entity types — are below.

Who can apply

This program is open to a diverse range of Indian entities committed to advancing Bio-AI in biomanufacturing. Eligible applicants include:

  • Companies established under the Companies Act 2013.
  • Startups.
  • Limited Liability Partnerships (LLPs) registered under the LLP Act 2008.
  • Academic institutions, universities, societies, trusts, NGOs, and foundations that are recognized as Scientific and Industrial Research Organizations (SIRO).

Startups and SMEs have a specific role, as they can participate as 'spokes' within the broader Bio-AI Hub model. In this capacity, they contribute specialized expertise while benefiting from the hub's shared infrastructure, mentorship, and access to advanced computational and biomanufacturing tools. All proposals must come from Indian entities and will be assessed based on their scientific merit, feasibility, and alignment with the BioE3 policy priorities.

DBT-BIRAC Joint Call for Proposals on Bio AI for Fostering High Performance Biomanufacturing under BioE3 Policy is open to startups at the idea and product stage working in health pharma biotech, agri food rural and climate energy ev. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and society.

ideaproducthealth pharma biotechagri food ruralclimate energy ev
Eligible stage
Idea · Product
Location
Open to startups registered in India
Entity type
Private Limited, Llp, Society, Trust, Academic

← Back to DBT-BIRAC Joint Call for Proposals on Bio AI for Fostering High Performance Biomanufacturing under BioE3 Policy overview